Synergy of de-walled Ganoderma Lucidum spore powder (GLSP) on targeted therapy in advanced non-squamous non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutant: protocol for a randomized, double-blind, placebo-controlled study.

Ganoderma lucidum

OncologyImmune supportMetabolic healthLiver support

SpeciesReishi, Lingzhi

JournalBMC complementary medicine and therapies

Year2024

Metadata-grounded summary

Article summary

Metadata-grounded summary: This clinical trial protocol indexes research on Ganoderma lucidum in BMC complementary medicine and therapies in 2024. MycoData maps the paper to oncology, immune support, metabolic health, liver support based on its title, species context, article metadata, and study classification.

Citation

Wu TT, Chen YY, Yuan ZC, Yang GW, Zhang GL (2024). Synergy of de-walled Ganoderma Lucidum spore powder (GLSP) on targeted therapy in advanced non-squamous non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutant: protocol for a randomized, double-blind, placebo-controlled study. BMC complementary medicine and therapies https://doi.org/10.1186/s12906-024-04416-2 PMID: 38500118

Open citation